Sanofi-Aventis Czech Republic made a net profit of CZK CZK 1.19 mil under revenues of CZK 6,120 mil in 2014, down 98.2% and -6.30%, respectively, when compared to the last year.
This translates into a net margin of 0.019%. Historically, the firm’s net margin reached an all time high of 3.45% in 2005 and an all time low of -0.099% in 2004. The average net margin in the last five years amounted to 0.609%.
On the operating level, EBITDA margin reached 0.163% and EBIT amounted to 0.278% of sales in 2014.
As far as Sanofi-Aventis Czech Republic's peers are concerned, Roche Czech Republic posted net and EBITDA margin of 2.17% and 6.07%, respectively in 2014, Bayer Czech Republic generated margins of 2.64% and 3.53% and Amgen Czech Republic's profit margin reached 6.36% on the net and 8.55% on the EBITDA level in 2014.